Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $4,035 | 4 | 25.0% |
| Honoraria | $4,000 | 1 | 24.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,000 | 1 | 24.7% |
| Food and Beverage | $2,755 | 40 | 17.0% |
| Travel and Lodging | $1,373 | 3 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UROGEN PHARMA, INC. | $6,181 | 10 | $0 (2024) |
| Boston Scientific Corporation | $4,315 | 4 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $3,692 | 4 | $0 (2024) |
| COLOPLAST CORP | $641.20 | 12 | $0 (2024) |
| AngioDynamics, Inc. | $434.35 | 4 | $0 (2022) |
| Janssen Research & Development, LLC | $280.00 | 5 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $157.49 | 2 | $0 (2024) |
| Photocure Inc | $89.05 | 2 | $0 (2022) |
| KARL STORZ Endoscopy-America | $87.16 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $78.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,980 | 15 | UROGEN PHARMA, INC. ($5,995) |
| 2023 | $517.22 | 8 | Janssen Research & Development, LLC ($180.00) |
| 2022 | $1,104 | 16 | Coloplast Corp ($422.62) |
| 2021 | $190.64 | 3 | AngioDynamics, Inc. ($112.47) |
| 2020 | $3,192 | 3 | Intuitive Surgical, Inc. ($3,192) |
| 2019 | $77.90 | 1 | AstraZeneca Pharmaceuticals LP ($77.90) |
| 2018 | $14.00 | 1 | PFIZER INC. ($14.00) |
| 2017 | $86.61 | 2 | BOSTON SCIENTIFIC CORPORATION ($46.52) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $98.26 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $59.23 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $500.00 | General |
| Category: SURGERY | ||||||
| 10/04/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $152.90 | General |
| Category: AMS 700_URO | ||||||
| 09/25/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: LithoVue_URO | ||||||
| 09/06/2024 | UROGEN PHARMA, INC. | — | Travel and Lodging | Cash or cash equivalent | $696.46 | General |
| 09/06/2024 | UROGEN PHARMA, INC. | — | Education | Cash or cash equivalent | $525.00 | General |
| 09/06/2024 | UROGEN PHARMA, INC. | — | Travel and Lodging | Cash or cash equivalent | $496.95 | General |
| 07/17/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Education | In-kind items and services | $10.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/26/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $59.37 | General |
| Category: Men's Health | ||||||
| 05/03/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Honoraria | Cash or cash equivalent | $4,000.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/03/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/03/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/22/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: General - IO Ablation_PI | ||||||
| 03/21/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/29/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/29/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/29/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 06/22/2023 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $48.02 | General |
| Category: Men's Health | ||||||
| 06/22/2023 | Coloplast Corp | Porges Coloplast (Device) | Food and Beverage | In-kind items and services | $48.02 | General |
| Category: Endourology | ||||||
| 06/20/2023 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $78.98 | General |
| Category: Oncology | ||||||
| 03/15/2023 | PALETTE LIFE SCIENCES, INC. | — | Food and Beverage | In-kind items and services | $75.04 | General |
| 02/08/2023 | KARL STORZ Endoscopy-America | Flex-X / IMAGE 1 S (Device) | Food and Beverage | In-kind items and services | $87.16 | General |
| Category: UROLOGY | ||||||
| 12/14/2022 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: Men's Health | ||||||
| 12/02/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $110.33 | General |
| Category: UROTHELIAL CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 340 | 479 | $199,275 | $31,315 |
| 2022 | 12 | 345 | 477 | $188,566 | $31,253 |
| 2021 | 12 | 281 | 366 | $177,870 | $27,190 |
| 2020 | 11 | 208 | 237 | $85,245 | $15,953 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 51 | $17,799 | $5,125 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 50 | 50 | $20,550 | $4,609 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 34 | 34 | $17,306 | $4,415 | 25.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 50 | 77 | $66,913 | $4,072 | 6.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 39 | 44 | $10,824 | $3,053 | 28.2% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 13 | 14 | $17,262 | $2,859 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 35 | $8,610 | $2,406 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,839 | $1,178 | 30.7% |
| 51702 | Simple insertion of temporary bladder tube | Facility | 2023 | 19 | 51 | $15,861 | $821.92 | 5.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 12 | 12 | $2,580 | $797.72 | 30.9% |
| 51701 | Insertion of temporary bladder tube | Facility | 2023 | 14 | 49 | $11,760 | $792.54 | 6.7% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 20 | 35 | $3,395 | $644.00 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 16 | $2,576 | $542.85 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 39 | 52 | $18,148 | $5,456 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 39 | 39 | $19,851 | $5,354 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 69 | $16,974 | $4,858 | 28.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 53 | 74 | $64,306 | $4,146 | 6.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 41 | 41 | $16,851 | $3,972 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 26 | $6,396 | $1,796 | 28.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 23 | $4,830 | $1,218 | 25.2% |
| 51701 | Insertion of temporary bladder tube | Facility | 2022 | 12 | 56 | $13,440 | $1,081 | 8.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,707 | $1,049 | 28.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Facility | 2022 | 13 | 23 | $10,764 | $682.16 | 6.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 12 | $1,932 | $625.69 | 32.4% |
| 51702 | Simple insertion of temporary bladder tube | Facility | 2022 | 18 | 30 | $9,330 | $605.98 | 6.5% |
About Charles Peyton
Charles Peyton is a Urology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1205195195.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Peyton has received a total of $16,163 in payments from pharmaceutical and medical device companies, with $10,980 received in 2024. These payments were reported across 49 transactions from 14 companies. The most common payment nature is "Education" ($4,035).
As a Medicare-enrolled provider, Peyton has provided services to 1,174 Medicare beneficiaries, totaling 1,559 services with total Medicare billing of $105,711. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Birmingham, AL
- Active Since 05/11/2012
- Last Updated 06/29/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1205195195
Products in Payments
- JELMYTO (Drug) $4,462
- Da Vinci Surgical System (Device) $3,692
- Titan (Device) $593.18
- NANOKNIFE (Device) $321.88
- ADSTILADRIN (Biological) $157.49
- AMS 700 (Device) $152.90
- LithoVue (Device) $115.43
- NanoKnife (Device) $112.47
- Flex-X / IMAGE 1 S (Device) $87.16
- ERLEADA (Drug) $78.98
- CYSVIEW (Drug) $74.05
- Porges Coloplast (Device) $48.02
- AMS (Device) $46.52
- Cysview (Drug) $15.00
- SUTENT (Drug) $14.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Birmingham
Dr. Thomas Chi, Md, MD
Urology — Payments: $470,805
Dr. Joel Funk, M.d, M.D
Urology — Payments: $338,628
Dr. Adam Baumgarten, M.d, M.D
Urology — Payments: $173,495
Kyle Wood
Urology — Payments: $81,887
Jeffrey Nix, M.d, M.D
Urology — Payments: $46,718
David Qi, M.d, M.D
Urology — Payments: $6,193